{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:22:23Z","timestamp":1790695343655,"version":"4.1.0"},"reference-count":298,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1210\/er.2018-00017","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T14:02:45Z","timestamp":1537452165000},"page":"193-235","source":"Crossref","is-referenced-by-count":135,"title":["Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review"],"prefix":"10.1210","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-2336","authenticated-orcid":false,"given":"Laura","family":"van Iersel","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E","family":"Brokke","sequence":"additional","affiliation":[{"name":"Medical Sciences, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A H","family":"Adan","sequence":"additional","affiliation":[{"name":"Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, Netherlands"},{"name":"Institute for Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C M","family":"Bulthuis","sequence":"additional","affiliation":[{"name":"Medical Sciences, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L T","family":"van den Akker","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Erasmus MC\u2013Sophia Children\u2019s Hospital, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke M","family":"van Santen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"issue":"5","key":"2019041122190022700_B1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrendo.2016.217","article-title":"New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma","volume":"13","author":"M\u00fcller","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"2019041122190022700_B2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program","volume":"14","author":"Zacharia","year":"2012","journal-title":"Neuro-oncol"},{"issue":"7","key":"2019041122190022700_B3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/neuonc\/nov044","article-title":"Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes","volume":"17","author":"Sterkenburg","year":"2015","journal-title":"Neuro-oncol"},{"issue":"6","key":"2019041122190022700_B4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EJE-17-0044","article-title":"Very long-term sequelae of craniopharyngioma","volume":"176","author":"Wijnen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019041122190022700_B5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00381-004-1124-y","article-title":"Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma","volume":"21","author":"M\u00fcller","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"2019041122190022700_B6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122190022700_B7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0707","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019041122190022700_B8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ijpo.12076","article-title":"Risk factors for mortality caused by hypothalamic obesity in children with hypothalamic tumours","volume":"11","author":"Haliloglu","year":"2016","journal-title":"Pediatr Obes"},{"issue":"7","key":"2019041122190022700_B9","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"M\u00fcller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122190022700_B10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jc.2002-021180","article-title":"Risk factors for the development of obesity in children surviving brain tumors","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122190022700_B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fendo.2011.00081","article-title":"Long term sequelae of pediatric craniopharyngioma\u2014literature review and 20 years of experience","volume":"2","author":"Cohen","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2019041122190022700_B12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2014.03.003","article-title":"The hypothalamic arcuate nucleus and the control of peripheral substrates","volume":"28","author":"Joly-Amado","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2019041122190022700_B13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.physbeh.2005.10.007","article-title":"The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight","volume":"87","author":"King","year":"2006","journal-title":"Physiol Behav"},{"issue":"6","key":"2019041122190022700_B14","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2012-3928","article-title":"Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity","volume":"98","author":"Elowe-Gruau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122190022700_B15","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/j.ijrobp.2011.01.005","article-title":"On the benefits and risks of proton therapy in pediatric craniopharyngioma","volume":"82","author":"Beltran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2019041122190022700_B16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40478-015-0211-5","article-title":"Identification of targets for rational pharmacological therapy in childhood craniopharyngioma","volume":"3","author":"Gump","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"2019041122190022700_B17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.12688\/f1000research.11549.1","article-title":"Recent advances in molecular pathology of craniopharyngioma","volume":"6","author":"Larkin","year":"2017","journal-title":"F1000 Res"},{"key":"2019041122190022700_B18","unstructured":"Vemurafenib and cobimetinib in treating patients with braf v600e mutation positive craniopharyngioma. Available at: www.clinicaltrials.gov\/ct2\/show\/NCT03224767?cond=craniopharyngioma&rank=9. Accessed 12 March 2017."},{"issue":"4","key":"2019041122190022700_B19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MED.0000000000000264","article-title":"Update on childhood craniopharyngiomas","volume":"23","author":"Cohen","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"2019041122190022700_B20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11102-016-0751-0","article-title":"Risk-adapted, long-term management in childhood-onset craniopharyngioma","volume":"20","author":"M\u00fcller","year":"2017","journal-title":"Pituitary"},{"issue":"5\u20136","key":"2019041122190022700_B21","first-page":"503","article-title":"Hypothalamic obesity in children: pathophysiology to clinical management","volume":"28","author":"Haliloglu","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"2019041122190022700_B22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1467-789X.2012.01004.x","article-title":"Hypothalamic obesity in children","volume":"13","author":"Bereket","year":"2012","journal-title":"Obes Rev"},{"issue":"10","key":"2019041122190022700_B23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/dmcn.13182","article-title":"Interventions for managing weight change following paediatric acquired brain injury: a systematic review","volume":"58","author":"Shah","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"2019041122190022700_B24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/obr.12534","article-title":"The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review","volume":"18","author":"Wang","year":"2017","journal-title":"Obes Rev"},{"issue":"4","key":"2019041122190022700_B25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tips.2008.01.008","article-title":"Anti-obesity drugs and neural circuits of feeding","volume":"29","author":"Adan","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2019041122190022700_B26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1037\/0735-7044.117.2.222","article-title":"Extracellular glutamate increases in the lateral hypothalamus during meal initiation, and GABA peaks during satiation: microdialysis measurements every 30 s","volume":"117","author":"Rada","year":"2003","journal-title":"Behav Neurosci"},{"issue":"3","key":"2019041122190022700_B27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0031-9384(86)90324-0","article-title":"Medial hypothalamic lesions in Syrian hamsters: characterization of hyperphagia and weight gain","volume":"36","author":"Rowland","year":"1986","journal-title":"Physiol Behav"},{"issue":"1","key":"2019041122190022700_B28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.neuro.30.051606.094324","article-title":"Neurobiology of feeding and energy expenditure","volume":"30","author":"Gao","year":"2007","journal-title":"Annu Rev Neurosci"},{"issue":"14","key":"2019041122190022700_B29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/10.14.1465","article-title":"Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus","volume":"10","author":"Michaud","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2019041122190022700_B30","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041122190022700_B31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/me.2008-0067","article-title":"Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice","volume":"22","author":"Kublaoui","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"9","key":"2019041122190022700_B32","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1210\/en.2003-0274","article-title":"Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets","volume":"144","author":"Diano","year":"2003","journal-title":"Endocrinology"},{"issue":"3","key":"2019041122190022700_B33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0143-4179(97)90054-8","article-title":"Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation","volume":"31","author":"Herv\u00e9","year":"1997","journal-title":"Neuropeptides"},{"issue":"9","key":"2019041122190022700_B34","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1523\/JNEUROSCI.4925-04.2005","article-title":"Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ","volume":"25","author":"Burdakov","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"2019041122190022700_B35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2011.10.008","article-title":"The role of the gut\/brain axis in modulating food intake","volume":"63","author":"Sam","year":"2012","journal-title":"Neuropharmacology"},{"key":"2019041122190022700_B36","doi-asserted-by":"crossref","first-page":"216S","DOI":"10.1038\/oby.2006.312","article-title":"Distributed neural control of energy balance: contributions from hindbrain and hypothalamus","volume":"14","author":"Grill","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"2019041122190022700_B37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1037\/0735-7044.108.2.347","article-title":"Neurological dissociation of gastrointestinal and metabolic contributions to meal size control","volume":"108","author":"Seeley","year":"1994","journal-title":"Behav Neurosci"},{"issue":"1\u20132","key":"2019041122190022700_B38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2003.08.036","article-title":"Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin","volume":"993","author":"Blevins","year":"2003","journal-title":"Brain Res"},{"issue":"5","key":"2019041122190022700_B39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/nutrit\/nuv002","article-title":"Food reward system: current perspectives and future research needs","volume":"73","author":"Alonso-Alonso","year":"2015","journal-title":"Nutr Rev"},{"issue":"4\u20135","key":"2019041122190022700_B40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0031-9384(88)90324-1","article-title":"Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens","volume":"44","author":"Hernandez","year":"1988","journal-title":"Physiol Behav"},{"issue":"Pt 22","key":"2019041122190022700_B41","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1113\/jphysiol.2009.179192","article-title":"Hormone and glucose signalling in POMC and AgRP neurons","volume":"587","author":"Belgardt","year":"2009","journal-title":"J Physiol"},{"issue":"1\u20133","key":"2019041122190022700_B42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-0115(02)00283-5","article-title":"Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting","volume":"111","author":"Bagnasco","year":"2003","journal-title":"Regul Pept"},{"issue":"3","key":"2019041122190022700_B43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nn.2739","article-title":"AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training","volume":"14","author":"Aponte","year":"2011","journal-title":"Nat Neurosci"},{"issue":"4","key":"2019041122190022700_B44","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1172\/JCI46229","article-title":"Rapid, reversible activation of AgRP neurons drives feeding behavior in mice","volume":"121","author":"Krashes","year":"2011","journal-title":"J Clin Invest"},{"issue":"11","key":"2019041122190022700_B45","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1210\/jc.2014-1680","article-title":"Diencephalic syndrome in childhood craniopharyngioma\u2014results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma","volume":"99","author":"Hoffmann","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122190022700_B46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-nutr-071811-150711","article-title":"Evolutionary perspectives on the obesity epidemic: adaptive, maladaptive, and neutral viewpoints","volume":"33","author":"Speakman","year":"2013","journal-title":"Annu Rev Nutr"},{"issue":"10","key":"2019041122190022700_B47","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1523\/JNEUROSCI.5444-09.2010","article-title":"Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression","volume":"30","author":"Tolson","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"2019041122190022700_B48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"issue":"2","key":"2019041122190022700_B49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI9238","article-title":"Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity","volume":"106","author":"Vaisse","year":"2000","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041122190022700_B50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00075197-200411000-00003","article-title":"Variability in energy expenditure and its components","volume":"7","author":"Donahoo","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"11","key":"2019041122190022700_B51","doi-asserted-by":"crossref","first-page":"E670","DOI":"10.3390\/nu8110670","article-title":"The energy content and composition of meals consumed after an overnight fast and their effects on diet induced thermogenesis: a systematic review, meta-analyses and meta-regressions","volume":"8","author":"Quatela","year":"2016","journal-title":"Nutrients"},{"issue":"5","key":"2019041122190022700_B52","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.2001.280.5.E740","article-title":"Direct evidence for tonic sympathetic support of resting metabolic rate in healthy adult humans","volume":"280","author":"Monroe","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"18","key":"2019041122190022700_B53","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1113\/JP272352","article-title":"Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis","volume":"594","author":"Gavini","year":"2016","journal-title":"J Physiol"},{"issue":"6","key":"2019041122190022700_B54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0928-4257(97)82408-4","article-title":"Acute lesions of the ventromedial hypothalamus reduce sympathetic activation and thermogenic changes induced by PGE1","volume":"91","author":"Monda","year":"1997","journal-title":"J Physiol Paris"},{"issue":"4","key":"2019041122190022700_B55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.0000090097.22678.0A","article-title":"Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus","volume":"42","author":"Marsh","year":"2003","journal-title":"Hypertension"},{"key":"2019041122190022700_B56","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1038\/oby.2006.310","article-title":"Leptin receptor signaling and action in the central nervous system","volume":"14","author":"Leshan","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"2019041122190022700_B57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-08-0533","article-title":"Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children","volume":"159","author":"Shaikh","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041122190022700_B58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1380089","article-title":"Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite","volume":"138","author":"Roth","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2019041122190022700_B59","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/ijo.2010.184","article-title":"Adaptive thermogenesis in humans","volume":"34","author":"Rosenbaum","year":"2010","journal-title":"Int J Obes"},{"key":"2019041122190022700_B60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-444-59602-4.00009-5","article-title":"Central regulation of the hypothalamo\u2013pituitary\u2013thyroid (HPT) axis: focus on clinical aspects","volume":"124","author":"Fliers","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"2019041122190022700_B61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000351249","article-title":"Thyroid hormones and the metabolic syndrome","volume":"2","author":"Iwen","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"14","key":"2019041122190022700_B62","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1073\/pnas.0805355106","article-title":"Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver","volume":"106","author":"Klieverik","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2019041122190022700_B63","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance","volume":"16","author":"L\u00f3pez","year":"2010","journal-title":"Nat Med"},{"key":"2019041122190022700_B64","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.redox.2017.04.019","article-title":"Traveling from the hypothalamus to the adipose tissue: the thermogenic pathway","volume":"12","author":"Contreras","year":"2017","journal-title":"Redox Biol"},{"issue":"2","key":"2019041122190022700_B65","doi-asserted-by":"crossref","first-page":"e56660","DOI":"10.1371\/journal.pone.0056660","article-title":"Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation","volume":"8","author":"Tanida","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"2019041122190022700_B66","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"2019041122190022700_B67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/endo-105-1-146","article-title":"Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats","volume":"105","author":"Berthoud","year":"1979","journal-title":"Endocrinology"},{"issue":"1","key":"2019041122190022700_B68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1021819318484","article-title":"Autonomic dysfunction of the \u03b2-cell and the pathogenesis of obesity","volume":"4","author":"Lustig","year":"2003","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2019041122190022700_B69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/bbrc.1996.0985","article-title":"Muscarinic stimulation increases Na+ entry in pancreatic B-cells by a mechanism other than the emptying of intracellular Ca2+ pools","volume":"224","author":"Miura","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019041122190022700_B70","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/gast.1996.v110.pm8608899","article-title":"Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation","volume":"110","author":"Kiba","year":"1996","journal-title":"Gastroenterology"},{"issue":"4","key":"2019041122190022700_B71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2006.02.009","article-title":"Role of hepatic STAT3 in brain-insulin action on hepatic glucose production","volume":"3","author":"Inoue","year":"2006","journal-title":"Cell Metab"},{"issue":"2","key":"2019041122190022700_B72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1037\/0735-7044.106.2.380","article-title":"Role of intrahypothalamic insulin in circadian patterns of food intake, activity, and body temperature","volume":"106","author":"McGowan","year":"1992","journal-title":"Behav Neurosci"},{"issue":"10","key":"2019041122190022700_B73","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.3390\/s101009002","article-title":"Glucose sensing neurons in the ventromedial hypothalamus","volume":"10","author":"Routh","year":"2010","journal-title":"Sensors (Basel)"},{"issue":"9","key":"2019041122190022700_B74","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/jcm4091774","article-title":"Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention","volume":"4","author":"Roth","year":"2015","journal-title":"J Clin Med"},{"issue":"11","key":"2019041122190022700_B75","doi-asserted-by":"crossref","first-page":"e76562","DOI":"10.1371\/journal.pone.0076562","article-title":"Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review","volume":"8","author":"Zada","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2019041122190022700_B76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1155\/1988\/291847","article-title":"Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrome","volume":"1","author":"Flynn","year":"1988","journal-title":"Behav Neurol"},{"issue":"5","key":"2019041122190022700_B77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000121200","article-title":"Neurobehavioral outcome in pediatric craniopharyngioma","volume":"26","author":"Anderson","year":"1997","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"2019041122190022700_B78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1469-8749.2010.03887.x","article-title":"Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma","volume":"53","author":"Hammond","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"2019041122190022700_B79","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0031-9384(87)90270-8","article-title":"Competitive behavior in male rats: aggression and success enhanced by medial hypothalamic lesions as well as by testosterone implants","volume":"40","author":"Albert","year":"1987","journal-title":"Physiol Behav"},{"issue":"1","key":"2019041122190022700_B80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000118545","article-title":"Abnormal food-seeking behavior after surgery for craniopharyngioma","volume":"21","author":"Skorzewska","year":"1989","journal-title":"Neuropsychobiology"},{"issue":"3","key":"2019041122190022700_B81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00381-010-1301-0","article-title":"Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma","volume":"27","author":"Ondruch","year":"2011","journal-title":"Childs Nerv Syst"},{"issue":"4\u20135","key":"2019041122190022700_B82","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s003810050207","article-title":"Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma","volume":"14","author":"Riva","year":"1998","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"2019041122190022700_B83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12020-017-1257-x","article-title":"First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma","volume":"56","author":"Hoffmann","year":"2017","journal-title":"Endocrine"},{"issue":"2","key":"2019041122190022700_B84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12020-016-1084-5","article-title":"Oxytocin in\u00a0survivors of childhood-onset craniopharyngioma","volume":"54","author":"Daubenb\u00fcchel","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"2019041122190022700_B85","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3171\/2015.4.PEDS159","article-title":"Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma","volume":"16","author":"Hua","year":"2015","journal-title":"J Neurosurg Pediatr"},{"issue":"33","key":"2019041122190022700_B86","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1200\/JCO.2005.03.8547","article-title":"Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy","volume":"24","author":"Kiehna","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019041122190022700_B87","first-page":"94","article-title":"Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function","volume":"104","author":"Merchant","year":"2006","journal-title":"J Neurosurg"},{"issue":"4","key":"2019041122190022700_B88","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1469-8749.2004.tb00476.x","article-title":"Outcome of craniopharyngioma in children: long-term complications and quality of life","volume":"46","author":"Poretti","year":"2004","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"2019041122190022700_B89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/JPEM.2006.19.1.15","article-title":"Health related quality of life and psychological outcome in patients treated for craniopharyngioma in childhood","volume":"19","author":"Pedreira","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2019041122190022700_B90","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/eje.1.02114","article-title":"Quality of life in treated adult craniopharyngioma patients","volume":"154","author":"Dekkers","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041122190022700_B91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cen.12523","article-title":"Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma","volume":"82","author":"Roemmler-Zehrer","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4 Pt 2","key":"2019041122190022700_B92","first-page":"R829","article-title":"Dissociative analysis of ventromedial hypothalamic obesity syndrome","volume":"259","author":"Parkinson","year":"1990","journal-title":"Am J Physiol"},{"issue":"9","key":"2019041122190022700_B93","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1210\/endo.137.9.8756584","article-title":"The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes","volume":"137","author":"Gettys","year":"1996","journal-title":"Endocrinology"},{"issue":"12","key":"2019041122190022700_B94","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-2007-979868","article-title":"Role of the \u03b23-adrenoceptor in the control of leptin expression","volume":"28","author":"Giacobino","year":"1996","journal-title":"Horm Metab Res"},{"issue":"1","key":"2019041122190022700_B95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2010.80","article-title":"Appetite-regulating hormone changes in patients with craniopharyngioma","volume":"19","author":"Roth","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"2019041122190022700_B96","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/jc.2004-2175","article-title":"Fasting ghrelin levels are not elevated in children with hypothalamic obesity","volume":"90","author":"Kanumakala","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122190022700_B97","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-13-0832","article-title":"Food intake regulating hormones in adult craniopharyngioma patients","volume":"170","author":"Roemmler-Zehrer","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019041122190022700_B98","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity","volume":"88","author":"Harz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041122190022700_B99","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1210\/jc.2010-0993","article-title":"Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma","volume":"95","author":"Holmer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041122190022700_B100","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/jc.2007-2672","article-title":"Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity","volume":"93","author":"Shaikh","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2019041122190022700_B101","first-page":"35","article-title":"Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma","volume":"28","author":"Hoffmann","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2019041122190022700_B102","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J Neuroendocrinol"},{"issue":"6","key":"2019041122190022700_B103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1530\/EJE-13-1025","article-title":"Sleep\u2013wake and melatonin pattern in craniopharyngioma patients","volume":"170","author":"Pickering","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2019041122190022700_B104","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10552-005-9012-7","article-title":"Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness","volume":"17","author":"M\u00fcller","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"6781","key":"2019041122190022700_B105","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/35010109","article-title":"Identification of sleep-promoting neurons in vitro","volume":"404","author":"Gallopin","year":"2000","journal-title":"Nature"},{"key":"2019041122190022700_B106","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.conb.2017.05.003","article-title":"Neuronal substrates of sleep homeostasis; lessons from flies, rats and mice","volume":"44","author":"Donlea","year":"2017","journal-title":"Curr Opin Neurobiol"},{"key":"2019041122190022700_B107","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neures.2017.03.013","article-title":"Hypothalamic regulation of the sleep\/wake cycle","volume":"118","author":"Ono","year":"2017","journal-title":"Neurosci Res"},{"issue":"6","key":"2019041122190022700_B108","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2010.11.032","article-title":"Sleep state switching","volume":"68","author":"Saper","year":"2010","journal-title":"Neuron"},{"issue":"10","key":"2019041122190022700_B109","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1523\/JNEUROSCI.20-10-03830.2000","article-title":"Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep","volume":"20","author":"Lu","year":"2000","journal-title":"J Neurosci"},{"issue":"3","key":"2019041122190022700_B110","first-page":"399","article-title":"Daily pattern of EEG activity in rats with lateral hypothalamic lesions","volume":"45","author":"Jurkowlaniec","year":"1994","journal-title":"J Physiol Pharmacol"},{"issue":"9197","key":"2019041122190022700_B111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"2019041122190022700_B112","doi-asserted-by":"crossref","first-page":"519607","DOI":"10.1155\/2010\/519607","article-title":"Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives","volume":"2010","author":"M\u00fcller","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2019041122190022700_B113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-017-2662-y","article-title":"Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors","volume":"136","author":"Khan","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"2019041122190022700_B114","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/ncomms3259","article-title":"The impact of sleep deprivation on food desire in the human brain","volume":"4","author":"Greer","year":"2013","journal-title":"Nat Commun"},{"issue":"11\u201312","key":"2019041122190022700_B115","first-page":"1305","article-title":"Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity","volume":"28","author":"Bomer","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2019041122190022700_B116","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1203\/pdr.0b013e3180332cd6","article-title":"Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma","volume":"61","author":"Roth","year":"2007","journal-title":"Pediatr Res"},{"issue":"1","key":"2019041122190022700_B117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(99)01922-8","article-title":"Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior","volume":"846","author":"Ruffin","year":"1999","journal-title":"Brain Res"},{"issue":"6","key":"2019041122190022700_B118","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cmet.2011.10.009","article-title":"NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways","volume":"14","author":"Vella","year":"2011","journal-title":"Cell Metab"},{"issue":"9","key":"2019041122190022700_B119","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00431-008-0876-x","article-title":"The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children","volume":"168","author":"Guran","year":"2009","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2019041122190022700_B120","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2265.2009.03639.x","article-title":"Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma","volume":"72","author":"Simoneau-Roy","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019041122190022700_B121","first-page":"163","article-title":"Hormonal factors influencing weight and growth pattern in craniopharyngioma","volume":"53","author":"Pinto","year":"2000","journal-title":"Horm Res"},{"issue":"1","key":"2019041122190022700_B122","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2431-9-24","article-title":"Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index","volume":"9","author":"Trivin","year":"2009","journal-title":"BMC Pediatr"},{"issue":"10","key":"2019041122190022700_B123","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0026-0495(95)90218-X","article-title":"Metabolic effects of growth hormone in humans","volume":"44","author":"M\u00f8ller","year":"1995","journal-title":"Metabolism"},{"issue":"4","key":"2019041122190022700_B124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2005.03.005","article-title":"Origin and development of GnRH neurons","volume":"16","author":"Whitlock","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2019041122190022700_B125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-11-0229","article-title":"Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma","volume":"165","author":"Holmer","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041122190022700_B126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2003-42722","article-title":"Perioperative dexamethasone treatment in childhood craniopharyngioma: influence on short-term and long-term weight gain","volume":"111","author":"M\u00fcller","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2019041122190022700_B127","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jc.2002-020511","article-title":"11\u03b2-Hydroxysteroid dehydrogenase activity in hypothalamic obesity","volume":"88","author":"Tiosano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041122190022700_B128","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2019041122190022700_B129","unstructured":"Higgins JP , GreenS, eds. Chapter 7: Selecting studies and collecting data. In: HigginsJP, GreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration; 2011. Available at: www.handbook.cochrane.org."},{"key":"2019041122190022700_B130","unstructured":"Higgins JP , AltmanDG, SterneJA, eds. Chapter 8: Assessing risk of bias in included studies. In: HigginsJP, GreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration; 2011. Available at: www.handbook.cochrane.org."},{"key":"2019041122190022700_B131","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"#cr-split#-2019041122190022700_B132.1","unstructured":"4. Sch??nemann H, Bro??ekJ, GuyattG, OxmanA, eds. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group"},{"key":"#cr-split#-2019041122190022700_B132.2","unstructured":"5. 2013. Available at: www.gdt.gradepro.org\/app\/handbook\/handbook.html. Access date 17 January 2018."},{"key":"2019041122190022700_B133","unstructured":"GRADEpro GDT: GRADEpro guideline development tool [software] . McMaster University; 2015 (developed by Evidence Prime, Inc.). Available from www.gradepro.org. Accessed 17 January 2018."},{"issue":"7650","key":"2019041122190022700_B134","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"2019041122190022700_B135","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.2002-030003","article-title":"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041122190022700_B136","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dom.12928","article-title":"A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity","volume":"19","author":"Shoemaker","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"2019041122190022700_B137","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1210\/jc.2016-2126","article-title":"Diazoxide in children with obesity after hypothalamic-pituitary lesions: a randomized, placebo-controlled trial","volume":"101","author":"Brauner","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041122190022700_B138","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archpedi.156.9.887","article-title":"The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma","volume":"156","author":"Mason","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2019041122190022700_B139","doi-asserted-by":"crossref","first-page":"417949","DOI":"10.1155\/2011\/417949","article-title":"Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1\u20132","key":"2019041122190022700_B140","first-page":"45","article-title":"Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience","volume":"28","author":"Kalina","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2 Pt 1","key":"2019041122190022700_B141","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3476(99)70017-X","article-title":"Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist","volume":"135","author":"Lustig","year":"1999","journal-title":"J Pediatr"},{"issue":"6","key":"2019041122190022700_B142","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/oby.21493","article-title":"A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity","volume":"24","author":"Lomenick","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"2019041122190022700_B143","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/oby.2009.491","article-title":"Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity","volume":"18","author":"Rakhshani","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"2019041122190022700_B144","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/EJE-12-0792","article-title":"Hypothalamic obesity: prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic","volume":"168","author":"Steele","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6\u20137","key":"2019041122190022700_B145","first-page":"344","article-title":"[Childhood craniopharyngioma with hypothalamic obesity\u2014no long-term weight reduction due to rehabilitation programs]","volume":"226","author":"Sterkenburg","year":"2014","journal-title":"Klin Padiatr"},{"issue":"2","key":"2019041122190022700_B146","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/JPEM.2006.19.2.129","article-title":"Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury","volume":"19","author":"Ismail","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"2019041122190022700_B147","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1210\/jc.2004-0667","article-title":"Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database)","volume":"89","author":"Geffner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122190022700_B148","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-12-0997","article-title":"GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases","volume":"168","author":"Zoicas","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2019041122190022700_B149","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2012.04409.x","article-title":"Bariatric surgery for morbid obesity in craniopharyngioma","volume":"78","author":"Weismann","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041122190022700_B150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ijo.2016.195","article-title":"Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up","volume":"41","author":"Wijnen","year":"2017","journal-title":"Int J Obes"},{"issue":"4","key":"2019041122190022700_B151","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/EJE-13-0280","article-title":"Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic\u2013pituitary dysfunction","volume":"169","author":"Yuen","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1\u20132","key":"2019041122190022700_B152","first-page":"59","article-title":"Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment","volume":"28","author":"Meijneke","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2019041122190022700_B153","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/000992289203100409","article-title":"Successful weight loss with protein-sparing modified fast in a morbidly obese boy with panhypopituitarism, diabetes insipidus, and defective thirst regulation","volume":"31","author":"Lee","year":"1992","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"2019041122190022700_B154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1098-108X(199607)20:1<111::AID-EAT13>3.0.CO;2-7","article-title":"Serotonergic agents in the treatment of hypothalamic obesity syndrome: a case report","volume":"20","author":"Jordaan","year":"1996","journal-title":"Int J Eat Disord"},{"issue":"4","key":"2019041122190022700_B155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2176\/nmc.41.210","article-title":"Mazindol administration improved hyperphagia after surgery for craniopharyngioma\u2014case report","volume":"41","author":"Sadatomo","year":"2001","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2019041122190022700_B156","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2011.00078","article-title":"Effects of methylphenidate on weight gain and food intake in hypothalamic obesity","volume":"2","author":"Elfers","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1\u20132","key":"2019041122190022700_B157","first-page":"53","article-title":"Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity","volume":"28","author":"van Santen","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2019041122190022700_B158","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000339469","article-title":"Treatment with glucagon-like peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumor","volume":"78","author":"Simmons","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2019041122190022700_B159","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2265.2012.04368.x","article-title":"A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus","volume":"77","author":"Thondam","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2019041122190022700_B160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.endinu.2016.10.006","article-title":"Hypothalamic obesity after craniopharyngioma surgery: treatment with a long acting glucagon like peptide 1 derivated","volume":"64","author":"Castro-Dufourny","year":"2017","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"8","key":"2019041122190022700_B161","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/ncpendmet0579","article-title":"Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy","volume":"3","author":"Inge","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"2019041122190022700_B162","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11102-011-0349-5","article-title":"Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery","volume":"15","author":"Page-Wilson","year":"2012","journal-title":"Pituitary"},{"issue":"8337","key":"2019041122190022700_B163","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(83)92437-6","article-title":"Truncal vagotomy in hypothalamic obesity","volume":"1","author":"Smith","year":"1983","journal-title":"Lancet"},{"issue":"3","key":"2019041122190022700_B164","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pjnns.2016.01.014","article-title":"Nucleus accumbens stimulation in pathological obesity","volume":"50","author":"Harat","year":"2016","journal-title":"Neurol Neurochir Pol"},{"issue":"8","key":"2019041122190022700_B165","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2169\/internalmedicine.44.832","article-title":"Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin","volume":"44","author":"Igaki","year":"2005","journal-title":"Intern Med"},{"issue":"6","key":"2019041122190022700_B166","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP.14.6.697","article-title":"Treatment of hypothalamic obesity with caffeine and ephedrine","volume":"14","author":"Greenway","year":"2008","journal-title":"Endocr Pract"},{"issue":"11","key":"2019041122190022700_B167","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/meta.2002.35591","article-title":"Triiodothyronine supplementation for hypothalamic obesity","volume":"51","author":"Fernandes","year":"2002","journal-title":"Metabolism"},{"issue":"9","key":"2019041122190022700_B168","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1515\/JPEM.2009.22.9.867","article-title":"Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma","volume":"22","author":"Rottembourg","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"2019041122190022700_B169","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0031-1284420","article-title":"Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB)","volume":"223","author":"M\u00fcller","year":"2011","journal-title":"Klin Padiatr"},{"issue":"4","key":"2019041122190022700_B170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/cen.12031","article-title":"Is bariatric surgery really inefficient in hypothalamic obesity","volume":"78","author":"Gatta","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041122190022700_B171","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11695-015-1977-z","article-title":"Postprandial GLP-1 secretion after bariatric surgery in three cases of severe obesity related to craniopharyngiomas","volume":"26","author":"Bretault","year":"2016","journal-title":"Obes Surg"},{"issue":"5","key":"2019041122190022700_B172","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4158\/EP15947.OR","article-title":"Hormone substitution after gastric bypass surgery in patients with hypopituitarism secondary to craniopharyngioma","volume":"22","author":"Wolf","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"2019041122190022700_B173","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13304-017-0425-0","article-title":"Sleeve gastrectomy leads to easy management of hormone replacement therapy and good weight loss in patients treated for craniopharyngioma","volume":"69","author":"Trotta","year":"2017","journal-title":"Updates Surg"},{"issue":"6","key":"2019041122190022700_B174","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"4","key":"2019041122190022700_B175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual Life Res"},{"key":"2019041122190022700_B176","unstructured":"National Institute for Health and Clinical Excellence. Improving outcomes for people with brain and other CNS tumours. Available at: www.nice.org.uk\/guidance\/csg10\/resources\/improving-outcomes-for-people-with-brain-and-other-central-nervous-system-tumours-update-27841361437. Accessed 15 January 2018."},{"key":"2019041122190022700_B177","doi-asserted-by":"crossref","first-page":"S554","DOI":"10.1016\/S0924-977X(11)70902-6","article-title":"Modulation of secondary binge-eating disorders by topiramate: a post surgery and radiotherapy panhypopituitary case","volume":"21","author":"Farisse","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"2019041122190022700_B178","first-page":"179","article-title":"Topiramate treatment for impulse control disorders. A case report of craniopharyngioma","volume":"10","author":"Burgos Mar\u00edn","year":"2003","journal-title":"Psiquiatr Biol."},{"key":"2019041122190022700_B179","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jocn.2015.12.007","article-title":"Emotional and personality changes following brain tumour resection","volume":"29","author":"Jenkins","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"8","key":"2019041122190022700_B180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/archdischild-2012-302250","article-title":"Question 3. Should stimulants be administered to manage difficulties with attention, hyperactivity and impulsivity following paediatric acquired brain injury","volume":"97","author":"Harvey","year":"2012","journal-title":"Arch Dis Child"},{"key":"2019041122190022700_B181","doi-asserted-by":"crossref","unstructured":"Ebner NC , LinT, MuradogluM, WeirDH, PlasenciaGM, LillardTS, Pournajafi-NazarlooH, CohenRA, Sue CarterC, ConnellyJJ. Associations between oxytocin receptor gene (OXTR) methylation, plasma oxytocin, and attachment across adulthood [published online ahead of print 2 February 2018]. Int J Psychophysiol. doi: 10.1016\/j.ijpsycho.2018.01.008.","DOI":"10.1016\/j.ijpsycho.2018.01.008"},{"issue":"7042","key":"2019041122190022700_B182","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"issue":"6","key":"2019041122190022700_B183","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","article-title":"Oxytocin improves \u201cmind-reading\u201d in humans","volume":"61","author":"Domes","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"7","key":"2019041122190022700_B184","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"9","key":"2019041122190022700_B185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2015.162","article-title":"The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial","volume":"21","author":"Yatawara","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2019041122190022700_B186","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/YCO.0000000000000391","article-title":"A review of clinical trials of oxytocin in Prader-Willi syndrome","volume":"31","author":"Rice","year":"2018","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"2019041122190022700_B187","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jc.2017-02080","article-title":"Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122190022700_B188","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1038\/oby.2002.192","article-title":"Dietary intake\u2014how do we measure what people are really eating","volume":"10","author":"Johnson","year":"2002","journal-title":"Obes Res"},{"issue":"27","key":"2019041122190022700_B189","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJM199212313272701","article-title":"Discrepancy between self-reported and actual caloric intake and exercise in obese subjects","volume":"327","author":"Lichtman","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041122190022700_B190","doi-asserted-by":"crossref","first-page":"1203S","DOI":"10.1093\/ajcn\/65.4.1203S","article-title":"Dietary methods research in the third National Health and Nutrition Examination Survey: underreporting of energy intake","volume":"65","author":"Briefel","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"2019041122190022700_B191","unstructured":"National Institutes of Health. National Children\u2019s Study Dietary Assessment Literature Review. Available at: www.epi.grants.cancer.gov\/past-initiatives\/assess_wc\/review\/pdf\/. Accessed 15 April 2018."},{"key":"2019041122190022700_B192","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/oby.20646","article-title":"Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia","volume":"22","author":"Heymsfield","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"Pt 4","key":"2019041122190022700_B193","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1348\/014466503322528928","article-title":"The assessment of food-related problems in individuals with Prader-Willi syndrome","volume":"42","author":"Russell","year":"2003","journal-title":"Br J Clin Psychol"},{"issue":"1","key":"2019041122190022700_B194","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.appet.2009.05.016","article-title":"The Power of Food Scale. A new measure of the psychological influence of the food environment","volume":"53","author":"Lowe","year":"2009","journal-title":"Appetite"},{"issue":"7","key":"2019041122190022700_B195","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/oby.2007.216","article-title":"Assessment of hyperphagia in Prader-Willi syndrome","volume":"15","author":"Dykens","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"2019041122190022700_B196","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122190022700_B197","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"2019041122190022700_B198","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"2019041122190022700_B199","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jama.2014.10397","article-title":"Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis","volume":"312","author":"Johnston","year":"2014","journal-title":"JAMA"},{"issue":"4\u20135","key":"2019041122190022700_B200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0031-9384(88)90325-3","article-title":"Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine","volume":"44","author":"Parada","year":"1988","journal-title":"Physiol Behav"},{"issue":"2","key":"2019041122190022700_B201","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ajcn\/86.2.308","article-title":"Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food","volume":"86","author":"Goldfield","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2019041122190022700_B202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(77)90124-8","article-title":"Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat","volume":"43","author":"Samanin","year":"1977","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2019041122190022700_B203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W","article-title":"Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report","volume":"21","author":"Schweickert","year":"1997","journal-title":"Int J Eat Disord"},{"issue":"2","key":"2019041122190022700_B204","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1098-108X(199903)25:2<233::AID-EAT14>3.0.CO;2-2","article-title":"Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder","volume":"25","author":"Sokol","year":"1999","journal-title":"Int J Eat Disord"},{"issue":"2","key":"2019041122190022700_B205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2019041122190022700_B206","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"2019041122190022700_B207","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","article-title":"Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"72","author":"McElroy","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"2019041122190022700_B208","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2019041122190022700_B209","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuron.2011.06.012","article-title":"Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels","volume":"71","author":"Sohn","year":"2011","journal-title":"Neuron"},{"issue":"1\u20133","key":"2019041122190022700_B210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2009.05.018","article-title":"Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis","volume":"615","author":"Mashiko","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2019041122190022700_B211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tins.2012.12.001","article-title":"Mechanisms underlying current and future anti-obesity drugs","volume":"36","author":"Adan","year":"2013","journal-title":"Trends Neurosci"},{"issue":"11","key":"2019041122190022700_B212","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1210\/jc.2007-0826","article-title":"Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes","volume":"92","author":"Danielsson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122190022700_B213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4093\/dmj.2012.36.1.13","article-title":"Anti-obesity drugs: a review about their effects and safety","volume":"36","author":"Kang","year":"2012","journal-title":"Diabetes Metab J"},{"key":"2019041122190022700_B214","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/DMSO.S56924","article-title":"Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity","volume":"7","author":"Joharapurkar","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"2019041122190022700_B215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1210\/en.2016-1665","article-title":"Robust reductions of excess weight and hyperphagia by beloranib in rat models of genetic and hypothalamic obesity","volume":"158","author":"Elfers","year":"2017","journal-title":"Endocrinology"},{"issue":"12","key":"2019041122190022700_B216","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"2019041122190022700_B217","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/dom.13305","article-title":"Single and multiple dose evaluation of a novel MetAP2 inhibitor: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"20","author":"Malloy","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2019041122190022700_B218","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/obr.12258","article-title":"Appetite and body weight regulation after bariatric surgery","volume":"16","author":"M\u00fcnzberg","year":"2015","journal-title":"Obes Rev"},{"issue":"6","key":"2019041122190022700_B219","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2012-4184","article-title":"Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis","volume":"98","author":"Bretault","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"2019041122190022700_B220","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery","volume":"351","author":"Sj\u00f6str\u00f6m","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2019041122190022700_B221","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s11695-012-0622-3","article-title":"Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial","volume":"22","author":"Peterli","year":"2012","journal-title":"Obes Surg"},{"issue":"17","key":"2019041122190022700_B222","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1523\/JNEUROSCI.3237-12.2013","article-title":"Amelioration of binge eating by nucleus accumbens shell deep brain stimulation in mice involves D2 receptor modulation","volume":"33","author":"Halpern","year":"2013","journal-title":"J Neurosci"},{"issue":"6","key":"2019041122190022700_B223","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/oby.21067","article-title":"Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity","volume":"23","author":"Roth","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"24","key":"2019041122190022700_B224","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.87.24.9868","article-title":"Brain magnetic resonance imaging with contrast dependent on blood oxygenation","volume":"87","author":"Ogawa","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019041122190022700_B225","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuroimage.2011.07.013","article-title":"MRI atlas of the human hypothalamus","volume":"59","author":"Baroncini","year":"2012","journal-title":"Neuroimage"},{"issue":"44","key":"2019041122190022700_B226","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1523\/JNEUROSCI.5412-09.2010","article-title":"A serotonin and melanocortin circuit mediates D-fenfluramine anorexia","volume":"30","author":"Xu","year":"2010","journal-title":"J Neurosci"},{"issue":"6","key":"2019041122190022700_B227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jne.12287","article-title":"5-Hydroxytryptamine medications for the treatment of obesity","volume":"27","author":"Burke","year":"2015","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"2019041122190022700_B228","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0706929","article-title":"The MC4 receptor and control of appetite","volume":"149","author":"Adan","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"17","key":"2019041122190022700_B229","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2174\/156802607782341028","article-title":"NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs","volume":"7","author":"MacNeil","year":"2007","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"2019041122190022700_B230","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metab"},{"issue":"1","key":"2019041122190022700_B231","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1038\/s41598-017-04600-0","article-title":"Oxytocin administration suppresses hypothalamic activation in response to visual food cues","volume":"7","author":"van der Klaauw","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"2019041122190022700_B232","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/oby.21069","article-title":"Oxytocin reduces caloric intake in men","volume":"23","author":"Lawson","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"2019041122190022700_B233","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db13-0663","article-title":"Oxytocin reduces reward-driven food intake in humans","volume":"62","author":"Ott","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"2019041122190022700_B234","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/cen.13169","article-title":"Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial","volume":"85","author":"Kuppens","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041122190022700_B235","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2019041122190022700_B236","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/mp.2017.27","article-title":"Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay","volume":"23","author":"Lee","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2019041122190022700_B237","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5665\/sleep.1642","article-title":"The consensus sleep diary: standardizing prospective sleep self-monitoring","volume":"35","author":"Carney","year":"2012","journal-title":"Sleep (Basel)"},{"issue":"6","key":"2019041122190022700_B238","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"2019041122190022700_B239","first-page":"97","article-title":"The assessment of sleepiness in children and adolescents","volume":"13","author":"Johns","year":"2015","journal-title":"Sleep Biol Rhythms"},{"issue":"4","key":"2019041122190022700_B240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/sleep\/9.4.519","article-title":"Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness","volume":"9","author":"Carskadon","year":"1986","journal-title":"Sleep"},{"issue":"6","key":"2019041122190022700_B241","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.sleep.2005.04.002","article-title":"Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma","volume":"6","author":"Tachibana","year":"2005","journal-title":"Sleep Med"},{"key":"2019041122190022700_B242","first-page":"423","article-title":"Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients","volume":"19","author":"M\u00fcller","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2019041122190022700_B243","first-page":"435","article-title":"Secondary narcolepsy in children with brain tumors","volume":"25","author":"Marcus","year":"2002","journal-title":"Sleep"},{"issue":"3","key":"2019041122190022700_B244","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.27497","article-title":"Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults","volume":"5","author":"Epstein","year":"2009","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"2019041122190022700_B245","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/sleep\/30.11.1445","article-title":"Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"issue":"10","key":"2019041122190022700_B246","first-page":"1277","article-title":"Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"11","key":"2019041122190022700_B247","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/sleep\/29.11.1415","article-title":"Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"2","key":"2019041122190022700_B248","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7326\/M15-1782","article-title":"Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the american college of physicians","volume":"165","author":"Brasure","year":"2016","journal-title":"Ann Intern Med"},{"issue":"10","key":"2019041122190022700_B249","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5664\/jcsm.5100","article-title":"Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD). An update for 2015: an American Academy of Sleep Medicine clinical practice guideline","volume":"11","author":"Auger","year":"2015","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"2019041122190022700_B250","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"issue":"6","key":"2019041122190022700_B251","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2265.2011.03993.x","article-title":"Somnolence in adult craniopharyngioma patients is a common, heterogeneous condition that is potentially treatable","volume":"74","author":"Crowley","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1 Pt 1","key":"2019041122190022700_B252","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1542\/peds.112.1.e46","article-title":"Sleep in children with neoplasms of the central nervous system: case review of 14 children","volume":"112","author":"Rosen","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"2019041122190022700_B253","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1542\/peds.2012-1672","article-title":"Diagnosis and management of childhood obstructive sleep apnea syndrome","volume":"130","author":"Marcus","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"2019041122190022700_B254","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/jc.2009-2003","article-title":"Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls","volume":"95","author":"O\u2019Gorman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041122190022700_B255","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","article-title":"Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients","volume":"87","author":"M\u00fcller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122190022700_B256","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.0b013e3181af78a5","article-title":"Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma","volume":"73","author":"Lipton","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"2019041122190022700_B257","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-079X.1998.tb00554.x","article-title":"Twenty-four hour rhythm of melatonin in patients with a history of pineal and\/or hypothalamo-neurohypophyseal germinoma","volume":"25","author":"Murata","year":"1998","journal-title":"J Pineal Res"},{"issue":"2","key":"2019041122190022700_B258","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-14-0172","article-title":"Alterations in diurnal rhythmicity in patients treated for nonfunctioning pituitary macroadenoma: a controlled study and literature review","volume":"171","author":"Joustra","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019041122190022700_B259","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.39.11.1505","article-title":"Narcolepsy associated with lesions of the diencephalon","volume":"39","author":"Aldrich","year":"1989","journal-title":"Neurology"},{"issue":"10","key":"2019041122190022700_B260","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1212\/WNL.34.10.1372","article-title":"Transient cataplexy after removal of a craniopharyngioma","volume":"34","author":"Schwartz","year":"1984","journal-title":"Neurology"},{"issue":"4","key":"2019041122190022700_B261","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2169\/internalmedicine.51.6101","article-title":"Possible mechanism of secondary narcolepsy with a long sleep time following surgery for craniopharyngioma","volume":"51","author":"Sakuta","year":"2012","journal-title":"Intern Med"},{"issue":"9","key":"2019041122190022700_B262","doi-asserted-by":"crossref","first-page":"15924","DOI":"10.3390\/ijms150915924","article-title":"Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders","volume":"15","author":"Laudon","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2019041122190022700_B263","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the pace clinical trial: effects of dronabinol in obstructive sleep apnea","volume":"41","author":"Carley","year":"2018","journal-title":"Sleep (Basel)"},{"issue":"6","key":"2019041122190022700_B264","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00421-009-1000-2","article-title":"Assessment of physical activity: a critical appraisal","volume":"105","author":"Westerterp","year":"2009","journal-title":"Eur J Appl Physiol"},{"issue":"7","key":"2019041122190022700_B265","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00421-017-3641-x","article-title":"Doubly labelled water assessment of energy expenditure: principle, practice, and promise","volume":"117","author":"Westerterp","year":"2017","journal-title":"Eur J Appl Physiol"},{"issue":"10","key":"2019041122190022700_B266","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"15","key":"2019041122190022700_B267","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041122190022700_B268","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2174\/1573399812666160517115450","article-title":"Classification of therapeutic and experimental drugs for brown adipose tissue activation: potential treatment strategies for diabetes and obesity","volume":"12","author":"Mukherjee","year":"2016","journal-title":"Curr Diabetes Rev"},{"issue":"2\u20133","key":"2019041122190022700_B269","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)01421-8","article-title":"\u03b23-Adrenoceptor agonists: potential, pitfalls and progress","volume":"440","author":"Arch","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2019041122190022700_B270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2014.12.009","article-title":"Activation of human brown adipose tissue by a \u03b23-adrenergic receptor agonist","volume":"21","author":"Cypess","year":"2015","journal-title":"Cell Metab"},{"issue":"7","key":"2019041122190022700_B271","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.ijo.0803223","article-title":"Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial","volume":"30","author":"Gadde","year":"2006","journal-title":"Int J Obes"},{"issue":"3","key":"2019041122190022700_B272","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4088\/JCP.v68n0306","article-title":"Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial","volume":"68","author":"McElroy","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2019041122190022700_B273","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000348792","article-title":"Successful treatment with atomoxetine of an adolescent boy with attention deficit\/hyperactivity disorder, extreme obesity, and reduced melanocortin 4 receptor function","volume":"6","author":"Pott","year":"2013","journal-title":"Obes Facts"},{"issue":"3","key":"2019041122190022700_B274","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cmet.2012.01.019","article-title":"PPAR\u03b3 agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein","volume":"15","author":"Ohno","year":"2012","journal-title":"Cell Metab"},{"issue":"6","key":"2019041122190022700_B275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/cr.2013.64","article-title":"Brown adipose tissue transplantation improves whole-body energy metabolism","volume":"23","author":"Liu","year":"2013","journal-title":"Cell Res"},{"issue":"1","key":"2019041122190022700_B276","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/2230-8210.146874","article-title":"Assessment of insulin sensitivity\/resistance","volume":"19","author":"Gutch","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"2019041122190022700_B277","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"39","key":"2019041122190022700_B278","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"2019041122190022700_B279","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology\u2014clinical practice guidelines for developing a diabetes mellitus comprehensive care plan\u20142015","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"issue":"10","key":"2019041122190022700_B280","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2008-0222","article-title":"Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an Endocrine Society clinical practice guideline","volume":"93","author":"Rosenzweig","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041122190022700_B281","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1210\/jc.2010-1047","article-title":"Insulin resistance in children: consensus, perspective, and future directions","volume":"95","author":"Levy-Marchal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2019041122190022700_B282","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2165\/00003495-200868140-00003","article-title":"Use of somatostatin analogues in obesity","volume":"68","author":"Tzotzas","year":"2008","journal-title":"Drugs"},{"issue":"9701","key":"2019041122190022700_B283","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"2019041122190022700_B284","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0000000000000095","article-title":"Effects of metformin on weight loss: potential mechanisms","volume":"21","author":"Malin","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2019041122190022700_B285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2012.01.028","article-title":"The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats","volume":"1444","author":"Lv","year":"2012","journal-title":"Brain Res"},{"key":"2019041122190022700_B286","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.3132\/dvdr.2007.053","article-title":"The role of fenofibrate in clinical practice","volume":"4","author":"Zambon","year":"2007","journal-title":"Diab Vasc Dis Res"},{"issue":"9","key":"2019041122190022700_B287","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"10148","key":"2019041122190022700_B288","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O\u2019Neil","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"2019041122190022700_B289","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041122190022700_B290","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society","volume":"85","author":"Growth Hormone Research Society","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122190022700_B291","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jcem-42-2-370","article-title":"Craniopharyngioma: the role of insulin in promoting postoperative growth","volume":"42","author":"Costin","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"issue":"36","key":"2019041122190022700_B292","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1200\/JCO.2016.70.1847","article-title":"Hypothalamic-pituitary axis dysfunction in survivors of childhood cns tumors: importance of systematic follow-up and early endocrine consultation","volume":"34","author":"Chemaitilly","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019041122190022700_B293","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041122190022700_B294","first-page":"91","article-title":"Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996","volume":"49","author":"Price","year":"1998","journal-title":"Horm Res"},{"issue":"6","key":"2019041122190022700_B295","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1530\/EJE-12-0077","article-title":"Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up","volume":"166","author":"Olsson","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019041122190022700_B296","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041122190022700_B297","first-page":"4472","article-title":"Diagnosis of hidden central hypothyroidism in survivors of childhood cancer","volume":"84","author":"Rose","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/40\/1\/193\/27507443\/er.2018-00017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T06:16:41Z","timestamp":1604989001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/40\/1\/193\/5103298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":298,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,20]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2018-00017","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,9,20]]}}}